V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002319 | 250007820 | 1.67 | 78.55 | Palliative (P) | 2018-06-01 | 2019-05-17 | ICON8B TRIAL | 02 | N | CARBOPLATIN + RT | 101205298 |
| 250002320 | 250007821 | null | null | Palliative (P) | null | 2019-09-24 | Carboplatin + Paclitaxel (3 weekly) | null | N | CARBOPLATIN + FLUOROURACIL | 101137656 |
| 250002332 | 250007823 | 1.55 | 79.2 | Palliative (P) | 2018-02-09 | 2018-02-13 | PACLITAXEL | 02 | N | PACLITAXEL | 101666138 |
| 250002342 | 250007827 | null | null | Palliative (P) | 2021-06-17 | 2021-06-17 | Carboplatin + Liposomal Doxorubicin | 02 | null | TRIAL UNSPECIFIED | 100644136 |
| 250002349 | 250007829 | 1.65 | 58 | Palliative (P) | 2018-07-03 | 2018-07-12 | Trial Unspecified | 02 | null | CAPECITABINE + CARBOPLATIN | 101207029 |
| 250002360 | 250007832 | null | null | null | null | 2020-05-21 | null | null | N | CISPLATIN + PEMETREXED | 101227963 |
| 250002366 | 250007834 | 1.77 | 66.3 | null | 2020-02-27 | 2020-02-27 | null | 02 | null | DOXORUBICIN | 100195240 |
| 250002381 | 250007837 | 1 | 114 | Palliative (P) | null | 2019-01-22 | Carbo F | null | null | EW EUROEWING 2012 ARM B VDC/IE | 101735266 |
| 250002383 | 250007838 | 1.8 | 82.65 | Palliative (P) | 2018-07-08 | 2018-07-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CARBOPLATIN + PEMETREXED | 101814106 |
| 250002384 | 250007839 | 1.78 | 65 | Palliative (P) | 2016-12-11 | 2016-12-11 | null | 02 | N | ATEZOLIZUMAB | 101724276 |
| 250002396 | 250007840 | 1.7 | 95.1 | null | 2019-12-23 | 2020-03-16 | Cyclophosphamide + Topotecan | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100619159 |
| 250002397 | 250007841 | 1.79 | 62.1 | Curative (C) | null | 2019-12-28 | Capecitabine (21 day) + Irinotecan | 02 | N | FLUOROURACIL + MITOMYCIN | 101234581 |
| 250002398 | 250007842 | null | null | Palliative (P) | 2019-01-07 | 2019-01-13 | PEMBROLIZUMAB + PEMETREXED | 02 | N | CARBOPLATIN + ETOPOSIDE | 100268931 |
| 250002399 | 250007843 | 1.05 | 91.3 | Curative (C) | 2017-02-19 | 2017-03-05 | Carboplatin AUC 2 - 5 | 02 | null | FLUOROURACIL + MITOMYCIN | 100263626 |
| 250002405 | 250007845 | 1.62 | 52.2 | Palliative (P) | 2017-03-18 | 2017-03-19 | Paclitaxel 7 day | 02 | N | TRIAL UNSPECIFIED | 100133184 |
| 250002406 | 250007846 | 1.71 | 52.2 | Palliative (P) | 2020-05-26 | 2020-05-28 | null | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101384826 |
| 250002408 | 250007848 | 1.79 | 74 | Curative (C) | 2020-03-15 | 2020-04-30 | AVELUMAB + AXITINIB | 02 | null | DINUTUXIMAB BETA | 101208463 |
| 250002410 | 250007849 | 1.65 | 61.3 | Curative (C) | 2020-01-18 | 2020-01-23 | null | 02 | N | CARBOPLATIN | 101773111 |
| 250002413 | 250007851 | 1.61 | 135.8 | Palliative (P) | 2021-05-26 | 2021-06-17 | Avelumab | 02 | null | NB HRNBL-1 COJEC IND COURSE B | 100158875 |
| 250002414 | 250007852 | 1.79 | 16.3 | null | 2018-04-02 | 2019-12-18 | null | 02 | N | DOCETAXEL + GEMCITABINE | 100241738 |
| 250002421 | 250007855 | 1.67 | 68 | Palliative (P) | 2021-05-27 | 2021-10-12 | CEDIRANIB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101452322 |
| 250002429 | 250007856 | 1.78 | 126.9 | Palliative (P) | null | 2019-11-25 | null | 02 | N | CARBOPLATIN | 100005118 |
| 250002430 | 250007857 | null | null | null | 2019-08-11 | 2019-08-21 | WT Guidelines Vinc/ActinoD | 01 | N | CABOZANTINIB | 100584231 |
| 250002431 | 250007858 | 1.65 | 60 | Palliative (P) | 2019-10-28 | 2019-11-11 | CARBOPLATIN + FLUOROURACIL | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100930843 |
| 250002432 | 250007859 | 1.85 | 101 | Palliative (P) | null | 2022-04-08 | null | 02 | N | CAPECITABINE + CARBOPLATIN | 101247903 |
| 250002433 | 250007860 | 1.7 | 59 | null | null | 2019-02-25 | null | 02 | null | TIVOZANIB | 101423039 |
| 250002434 | 250007861 | 0.83 | 74.7 | null | 2019-09-17 | 2019-09-17 | null | 02 | null | NB BEACON DINUTUXIMAB + TEMOZOLOMIDE + TOPOTECAN | 101792055 |
| 250002439 | 250007863 | 1.51 | 61.45 | null | 2017-09-02 | 2018-03-06 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | CAPECITABINE + OXALIPLATIN | 101632708 |
| 250002440 | 250007864 | null | null | null | null | 2019-11-05 | null | null | null | TIVOZANIB | 101694139 |
| 250002445 | 250007867 | 1.93 | 88 | null | 2017-08-21 | 2017-12-03 | Carboplatin + Liposomal Doxorubicin | 01 | N | FLUOROURACIL + IRINOTECAN | 101186520 |
| 250002460 | 250007868 | 1.84 | 44.7 | null | 2020-02-19 | 2020-02-26 | Cisplatin | 02 | Y | BORTEZOMIB | 100235580 |
| 250002472 | 250007872 | 1.78 | 154 | Palliative (P) | 2020-06-27 | 2020-07-08 | NB HRNBL-1 Isotretinoin | null | N | CISPLATIN + FLUOROURACIL | 100498184 |
| 250002477 | 250007873 | 0 | 95.6 | Palliative (P) | 2018-06-13 | 2018-06-16 | null | 02 | null | CYCLOPHOSPHAMIDE | 100258482 |
| 250002488 | 250007875 | 1.78 | 88 | Adjuvant (A) | 2020-04-25 | 2020-04-26 | CARBOPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN | 101074717 |
| 250002493 | 250007877 | 1.6 | 24.1 | null | null | 2019-10-15 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100390503 |
| 250002496 | 250007879 | 1.7 | 13.1 | null | 2021-02-25 | 2021-06-13 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | CETUXIMAB | 101022174 |
| 250002498 | 250007880 | null | null | Palliative (P) | null | 2022-04-17 | VAI (Ifos 3g/m2) | null | null | CISPLATIN | 101816101 |
| 250002499 | 250007881 | 1.8 | 106 | null | 2018-08-09 | 2018-12-09 | Imatinib 400mg | 02 | null | SUNITINIB | 101290057 |
| 250002501 | 250007882 | 1.82 | 87.5 | null | 2017-03-05 | 2017-03-20 | Cisplatin + Doxorubicin | 02 | N | CAPECITABINE + CARBOPLATIN | 101423802 |
| 250002502 | 250007883 | 1.88 | 61.3 | Curative (C) | 2020-02-14 | 2020-02-14 | NB HRNBL-1 Isotretinoin | 02 | N | CAPECITABINE + OXALIPLATIN | 100633098 |
| 250002512 | 250007889 | 1.56 | 86.9 | null | 2019-07-23 | 2019-07-23 | Abiraterone | 02 | N | NOT MATCHED | 101653937 |
| 250002515 | 250007890 | null | null | null | null | 2019-03-19 | null | null | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101254913 |
| 250002525 | 250007893 | 1.58 | 119 | Palliative (P) | 2021-05-09 | 2021-05-09 | CHOP R - 21 days | 02 | N | LIPOSOMAL DOXORUBICIN | 100606801 |
| 250002529 | 250007894 | 1.65 | null | Palliative (P) | 2019-05-14 | 2019-06-01 | ICON8B TRIAL | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100323076 |
| 250002533 | 250007896 | 1.53 | 78.8 | Palliative (P) | 2018-12-07 | 2018-12-30 | ICON9 TRIAL | 02 | null | CARBOPLATIN | 101026923 |
| 250002537 | 250007897 | null | null | null | 2019-05-26 | 2019-06-21 | Dinutuximab Beta | 02 | Y | TIVOZANIB | 100221084 |
| 250002541 | 250007898 | null | null | null | null | 2019-11-22 | PACLITAXEL | Y | null | ATEZOLIZUMAB | 100870402 |
| 250002543 | 250007899 | null | null | null | 2017-01-28 | 2017-02-10 | CARBOPLATIN + FLUOROURACIL | 02 | null | AVELUMAB | 100880144 |
| 250000106 | 250007901 | null | null | Palliative (P) | 2020-06-15 | 2020-06-20 | CISPLATIN + RT | 02 | null | BACILLUS CALMETTE-GUERIN | 101580077 |
| 250000218 | 250007903 | 1.76 | 60 | Palliative (P) | 2018-09-13 | 2018-11-07 | Carboplatin AUC 2 - 5 | 02 | null | ENZALUTAMIDE | 101444568 |